World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
97
Citations
33217
World Ranking
9315
National Ranking
903

Ignac Fogelman publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Ignac Fogelman sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 695 publications — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Ignac Fogelman D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Ignac Fogelman sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 97 D-Index — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Ignac Fogelman was affiliated with King's College London in the United Kingdom. Their research primarily focused on Medicine, with significant contributions in Psychiatry and Mental Health, Physiology, and Molecular Biology. The work also extended to Pediatrics, Perinatology and Child Health, as well as Economics and Econometrics.

Their research topics included:

  • Dementia and Cognitive Impairment Research
  • Alzheimer's disease research and treatments
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Pharmacological Effects and Toxicity Studies
  • Epilepsy research and treatment
  • Health Systems, Economic Evaluations, Quality of Life
  • Prion Diseases and Protein Misfolding

Fogelman contributed to multiple publications in several scientific venues. Frequent publication venues included:

  • Alzheimer s & Dementia
  • Annals of Clinical and Translational Neurology
  • Molecular Neurodegeneration
  • Clinica Chimica Acta
  • JAMA Network Open

They coauthored numerous papers with a range of colleagues, the most frequent of whom were:

  • Tim West
  • Joel B. Braunstein
  • Philip B. Verghese
  • Kevin E. Yarasheski
  • Kristopher M. Kirmess

Selected recent publications included:

  • "A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis" (2021) published in Molecular Neurodegeneration
  • "The PrecivityAD™ test: Accurate and reliable LC-MS/MS assays for quantifying plasma amyloid beta 40 and 42 and apolipoprotein E proteotype for the assessment of brain amyloidosis" (2021) published in Clinica Chimica Acta
  • "Assessment of a Plasma Amyloid Probability Score to Estimate Amyloid Positron Emission Tomography Findings Among Adults With Cognitive Impairment" (2022) published in JAMA Network Open
  • "Clinical validation of the PrecivityAD2 blood test: A mass spectrometry-based test with algorithm combining %p-tau217 and Aβ42/40 ratio to identify presence of brain amyloid" (2024) published in Alzheimer s & Dementia
  • "A blood biomarker test for brain amyloid impacts the clinical evaluation of cognitive impairment" (2023) published in Annals of Clinical and Translational Neurology

Best Publications

  • Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

    Michael R. McClung;Piet Geusens;Paul D. Miller;Hartmut Zippel

  • Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 gene.

    Struan F. A. Grant;David M. Reid;Glen Blake;Ruth Herd

  • Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions.

    Gary J. Cook;Stephen Houston;Robert Rubens;Michael N. Maisey

  • The role of DXA bone density scans in the diagnosis and treatment of osteoporosis.

    Glen M Blake;Ignac Fogelman

  • A UK Consensus Group on management of glucocorticoid‐induced osteoporosis: an update

    R. Eastell;D. M. Reid;J. Compston;C. Cooper

  • Goserelin Versus Cyclophosphamide, Methotrexate, and Fluorouracil as Adjuvant Therapy in Premenopausal Patients With Node-Positive Breast Cancer: The Zoladex Early Breast Cancer Research Association Study

    W Jonat;M Kaufmann;W Sauerbrei;R Blamey

  • Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: Potential for error in interpretation

    Gary J.R. Cook;Ignac Fogelman;Michael N. Maisey

  • Technical principles of dual energy x-ray absorptiometry

    Glen M. Blake;Ignac Fogelman

  • A dose-controlled study of 153Sm-Ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastase

    I. Resche;J.-F. Chatal;A. Pecking;P. Ell

  • Quantitative studies of bone with the use of 18F-fluoride and 99mTc-methylene diphosphonate

    Glen M. Blake;So-Jin Park-Holohan;Gary J.R. Cook;Ignac Fogelman

  • Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging

    Gary J.R Cook;Eva A Wegner;Ignac Fogelman

  • Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine.

    Gary J. R. Cook;Michael N. Maisey;Ignac Fogelman

  • Risedronate reverses bone loss in postmenopausal women with low bone mass: results from a multinational, double-blind, placebo-controlled trial. BMD-MN Study Group.

    I Fogelman;C Ribot;R Smith;D Ethgen

  • Positron emission tomography and bone metastases.

    Ignac Fogelman;Gary Cook;Ora Israel;Hans Van der Wall

  • Management of male osteoporosis: report of the UK Consensus Group.

    R. Eastell;I. T. Boyle;J. Compston;C. Cooper

  • The use of whole-body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease.

    Ignac Fogelman;Rodney G. Bessent;John G. Turner;Dennis L. Citrin

  • Compliance with hormone replacement therapy (HRT) after screening for post menopausal osteoporosis.

    P J Ryan;R Harrison;Glen Blake;Ignac Fogelman

  • The role of fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast.

    Werner Langsteger;Martin Heinisch;Ignac Fogelman

  • The use of F-18 choline PET in the assessment of bone metastases in prostate cancer: correlation with morphological changes on CT.

    Mohsen Beheshti;Reza Vali;Peter Waldenberger;Friedrich Fitz

  • Detection of bone metastases in breast cancer by 18FDG PET: Differing metabolic activity in osteoblastic and osteolytic lesions

    Gary Cook;S. Houston;Michael Maisey;Ignac Fogelman

Frequent Co-Authors

Tim D. Spector
Tim D. Spector King's College London
Robert E. Coleman
Robert E. Coleman University of Sheffield
Brendan F. Boyce
Brendan F. Boyce University of Rochester Medical Center
Richard Eastell
Richard Eastell University of Sheffield
Jean-Yves Reginster
Jean-Yves Reginster University of Liège
Stuart H. Ralston
Stuart H. Ralston University of Edinburgh
William D. Fraser
William D. Fraser Université de Sherbrooke
Juliet E. Compston
Juliet E. Compston University of Cambridge
Martin Schumacher
Martin Schumacher University of Freiburg
Jack Cuzick
Jack Cuzick Queen Mary University of London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Aspiring medical professionals have more flexible options than ever for advancing their careers online. For those interested in mental health care, accredited psych nurse practitioner programs prepare you to provide specialized psychiatric services, with some programs designed for quick completion.

If you’re passionate about the administrative side of healthcare, a health administration degree can be earned fully online, equipping graduates for leadership roles in hospitals, clinics, and public health organizations.

For those who already hold a bachelor's degree, there are many affordable mha online programs. These enable students to deepen their knowledge and open the door to advanced management positions without the need to pause their careers.

Nursing professionals seeking the highest clinical education may consider the most affordable dnp programs online. These programs are designed for flexibility and help nurses achieve leadership and advanced practice credentials efficiently.

Best Scientists Citing Ignac Fogelman

Recently Published Articles